Dermatofibroma natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Dermatofibroma}} | {{Dermatofibroma}} | ||
{{CMG}};{{AE}}{{Homa}} | {{CMG}};{{AE}}{{Homa}} | ||
==Overview== | ==Overview== | ||
Dermatofibroma usually [[Development|develops]] in the third decade of life, and most of them are [[asymptomatic]]. Common [[complications]] of dermatofibroma are related to [[Excision|excisional]] removing of the [[lesion]] and include, [[bleeding]], [[infection]] and [[scar]]. [[Prognosis]] is generally excellent. Although, in very [[rare]] cases [[metastases]] are seen. | |||
Common complications of [ | |||
Prognosis is generally excellent | |||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
* | *Dermatofibroma usually [[Development|develops]] in the third decade of life, and most of them are [[asymptomatic]].<ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}</ref> | ||
===Complications=== | ===Complications=== | ||
*Common complications of [ | *Common [[complications]] of dermatofibroma are related to [[Excision|excisional]] removing of the [[lesion]] and include:<ref>{{Cite journal | ||
**[ | | author = [[David J.. Myers]] & [[Eric P.. Fillman]] | ||
**[ | | title = Dermatofibroma | ||
**[ | | year = 2019 | ||
| month = | |||
| pmid = 29262213 | |||
|url=|first=|date=|journal=|volume=|pages=|via=}}</ref> | |||
**[[Bleeding]] | |||
**[[Infection]] | |||
**[[Scar]] | |||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally excellent | *[[Prognosis]] is generally excellent. Although, in very [[rare]] cases [[metastases]] are seen.<ref name="RomanoFritchie2017">{{cite journal|last1=Romano|first1=Ryan C.|last2=Fritchie|first2=Karen J.|title=Fibrohistiocytic Tumors|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=603–631|issn=02722712|doi=10.1016/j.cll.2017.05.007}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma natural history, complications and prognosis |
|
FDA on Dermatofibroma natural history, complications and prognosis |
|
CDC on Dermatofibroma natural history, complications and prognosis |
|
Dermatofibroma natural history, complications and prognosis in the news |
|
Blogs on Dermatofibroma natural history, complications and prognosis |
|
Risk calculators and risk factors for Dermatofibroma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic. Common complications of dermatofibroma are related to excisional removing of the lesion and include, bleeding, infection and scar. Prognosis is generally excellent. Although, in very rare cases metastases are seen.
Natural History, Complications, and Prognosis
Natural History
- Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic.[1][2][3]
Complications
- Common complications of dermatofibroma are related to excisional removing of the lesion and include:[4]
Prognosis
- Prognosis is generally excellent. Although, in very rare cases metastases are seen.[5]
References
- ↑ Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). "Phosphohistone-H3 and Ki67". The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
- ↑ Buehler, Darya; Weisman, Paul (2017). "Soft Tissue Tumors of Uncertain Histogenesis". Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
- ↑ Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). "A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)". Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
- ↑ David J.. Myers & Eric P.. Fillman (2019). "Dermatofibroma". PMID 29262213.
- ↑ Romano, Ryan C.; Fritchie, Karen J. (2017). "Fibrohistiocytic Tumors". Clinics in Laboratory Medicine. 37 (3): 603–631. doi:10.1016/j.cll.2017.05.007. ISSN 0272-2712.